5‐HFAA in Cerebrospinal Fluid
- 1 August 1970
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 12 (4) , 539-541
- https://doi.org/10.1111/j.1469-8749.1970.tb01957.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The effect of L-Dopa on monoamine metabolites in Parkinson's diseaseCellular and Molecular Life Sciences, 1970
- 5‐Hydroxyindoleacetic Acid in Cerebrospinal Fluid after Administration of 5‐Hydroxytryptophan IActa Pharmacologica et Toxicologica, 1968
- Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's DiseaseNature, 1968
- CSF 5HIAA: Effects of probenecid and parachlorophenylalanineLife Sciences, 1968
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecidLife Sciences, 1966
- Platelet Function Tests in Thrombocythaemia and ThrombocytosisBritish Journal of Haematology, 1966
- The metabolism of 5-hydroxytryptamine (serotonin) in the newbornThe Journal of Pediatrics, 1965
- Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded childrenThe Journal of Pediatrics, 1961
- 5-HYDROXYINDOLES IN MENTAL DEFICIENCYJournal of Neurology, Neurosurgery & Psychiatry, 1960